Nippon Shinyaku Co., Ltd.
General ticker "NPNKF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.5B (TTM average)
Nippon Shinyaku Co., Ltd. does not follow the US Stock Market performance with the rate: -19.2%.
Estimated limits based on current volatility of 6.7%: low 28.86$, high 33.03$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.42$ (Y1.38%)
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [40.21$, 65.99$]
- 2025-03-31 to 2026-03-31 estimated range: [40.17$, 66.17$]
Financial Metrics affecting the NPNKF estimates:
- Negative: with PPE of 21.0 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 21.17 > 18.64
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.94 > 6.04
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 83.61 > 63.39
- Positive: Interest expense per share per price, % of 0.06 <= 0.79
- Positive: Industry inventory ratio change (median), % of -0.37 <= -0.15
- Positive: 0.33 < Operating cash flow per share per price, % of 2.88
Short-term NPNKF quotes
Long-term NPNKF plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | ¥137,484.00MM | ¥144,175.00MM | ¥148,255.00MM |
| Operating Expenses | ¥104,536.00MM | ¥114,126.00MM | ¥116,869.00MM |
| Operating Income | ¥32,948.00MM | ¥30,049.00MM | ¥31,386.00MM |
| Non-Operating Income | ¥353.00MM | ¥440.00MM | ¥2,230.00MM |
| Interest Expense | ¥119.00MM | ¥136.00MM | ¥329.00MM |
| R&D Expense | ¥22,863.00MM | ¥24,135.00MM | ¥31,676.00MM |
| Income(Loss) | ¥33,301.00MM | ¥30,489.00MM | ¥33,616.00MM |
| Taxes | ¥8,303.00MM | ¥7,669.00MM | ¥7,762.00MM |
| Profit(Loss)* | ¥24,986.00MM | ¥22,812.00MM | ¥25,851.00MM |
| Stockholders Equity | ¥180,584.00MM | ¥195,624.00MM | ¥220,224.00MM |
| Inventory | ¥38,066.00MM | ¥36,358.00MM | ¥39,111.00MM |
| Assets | ¥219,943.00MM | ¥237,451.00MM | ¥263,404.00MM |
| Operating Cash Flow | ¥21,316.00MM | ¥26,170.00MM | ¥16,289.00MM |
| Capital expenditure | ¥8,943.00MM | ¥11,728.00MM | ¥9,649.00MM |
| Investing Cash Flow | ¥-10,037.00MM | ¥-17,631.00MM | ¥-9,921.00MM |
| Financing Cash Flow | ¥-8,407.00MM | ¥-9,605.00MM | ¥-9,719.00MM |
| Earnings Per Share** | ¥370.97 | ¥338.70 | ¥383.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.